Gene Therapy Trials for Hemophilia A

Event Registration

Gene Therapy Trials for Hemophilia A: Where We Are and What Comes Next

Join us for a special event to learn about the BioMarin gene therapy clinical trial program for hemophilia A. This virtual event aims to give you a closer look at how the clinical trials were designed and our current progress.

For people with hemophilia A and caregivers:

January 28^th, 2021

4:00 pm PT / 7:00 pm ET

For healthcare providers:

January 19^th, 2021

4:00 pm PT / 7:00 pm ET

For HCPs, if you are unable to attend this event,
please reach out to your Medical Science Liaison (MSL).

Virtual event

1-hour panel discussion
30-minute live Q&A

Here’s what we’ll discuss

A general overview of the clinical trial process
A closer look at the gene therapy clinical trial program for hemophilia A and its current progress
BioMarin's approach to advocacy for the hemophilia community

Presented By

Dr. Doris Quon

Dr. Quon is board certified in Hematology & Oncology and Internal Medicine. She obtained her M.D., Ph.D. at the UCLA David Geffen School of Medicine and did her Residency in Internal Medicine as well as Fellowship in Hematology-Oncology at UCLA Medical Center. She first began her residency training at the Orthopaedic Hemophilia Treatment Center (OHTC) back in 2000 and is currently the Medical Director of OHTC. She has an active role in coordinating the federally funded Region IX Hemophilia activities for the center and is the Medical Director of the Hemophilia Foundation of Southern California.

(* Required field)

Select the event that you would like to attend

*First Name

*Last Name

*Email Address

*Zip Code

*State

Phone number

*Which best describes you?

Do you have any questions for BioMarin?

Count me in for this event. By checking this box and clicking REGISTER below, I confirm I am at least 18 years old; confirm I agree to BioMarin's Privacy Policy and CCPA Notice and Terms of Use.

By checking this box and clicking REGISTER below, I consent to BioMarin, its successors, agents, and/or assigns using the email address I have provided to keep me informed about news and developments, market research or surveys, or other opportunities that may be of interest to me; and confirm I understand these communications/materials may contain information that markets or advertises BioMarin products, goods, or services.

By checking this box and clicking REGISTER below, I consent to BioMarin, its successors, agents, and/or assigns using the phone number I have provided to phone and/or text me with communications/messages that contain information marketing BioMarin's products, goods, or services, including via use of an automatic telephone dialing system; and confirm I understand I am not required to provide my consent as a condition of purchasing or renting any products, goods, or services.